| Heading: |
Drugs: Import Duties |
| Question ID: |
1795172 |
| UIN: |
46601 |
| House: |
Commons |
| Date tabled: |
2025-04-17 |
| Asking Member ID: |
5335 |
| Asking Member display name: |
Jess Brown-Fuller
|
| Asking Member handle: |
JessBrownFuller
|
| Asking Member Twitter reference: |
@JessBrownFuller
|
| Member interest: |
false |
| Question text: |
To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential impact of US tariffs on the UK pharmaceutical industry. |
| Is named day: |
false |
| Date of holding answer: |
|
| Date answered: |
2025-05-06 |
| Date answer corrected: |
|
| Is holding answer: |
false |
| Is correcting answer: |
false |
| Answering Member ID: |
4444 |
| Answering Member display name: |
Karin Smyth
|
| Answering Member handle: |
karinsmyth
|
| Answering Member Twitter reference: |
@karinsmyth
|
| Correcting Member ID: |
|
| Correcting Member display name: |
|
| Correcting Member handle: |
|
| Correcting Member Twitter reference: |
|
| Answer text: |
The Department is working closely with United Kingdom pharmaceutical firms and trade associations to understand how United States tariffs may impact the sector and the trade of individual products. As this is an evolving situation, these assessments are o... |
| Original answer text: |
|
| Comparable answer text: |
|
| Answering body ID: |
17 |
| Answering body name: |
Department of Health and Social Care |
| Tweeted: |
true |